Related references
Note: Only part of the references are listed.Long-Term Antihypertensive Efficacy and Safety of the Oral Direct Renin Inhibitor Aliskiren A 12-Month Randomized, Double-Blind Comparator Trial With Hydrochlorothiazide
Roland E. Schmieder et al.
CIRCULATION (2009)
Prognostic Value of Biomarkers During and After Non-ST-Segment Elevation Acute Coronary Syndrome
Kai M. Eggers et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Effects of the Oral Direct Renin Inhibitor Aliskiren in Patients With Symptomatic Heart Failure
John J. V. McMurray et al.
CIRCULATION-HEART FAILURE (2008)
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial
S. Yusuf et al.
LANCET (2008)
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study):: a multicentre, randomised, double-blind, controlled trial
Johannes F. E. Mann et al.
LANCET (2008)
Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial
Suzanne Oparil et al.
LANCET (2007)
Heart failure with preserved left ventricular systolic function among patients with non-ST-segment elevation acute coronary syndromes
Kyla M. Bennett et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study
BM Scirica et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease
DA Morrow et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients
AH Gradman et al.
CIRCULATION (2005)
Determinants and prognostic impact of heart failure complicating acute coronary syndromes observations from The Global Registry of Acute Coronary Events (GRACE)
PG Steg et al.
CIRCULATION (2004)
B-Type natriuretic peptide at presentation and prognosis in patients with ST-Segment elevation myocardial infarction - An ENTIRE-TIMI-23 substudy
JL Mega et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Analytical and clinical evaluation of the Bayer ADVIA centaur automated B-type natriuretic peptide assay in patients with heart failure: A multisite study
AHB Wu et al.
CLINICAL CHEMISTRY (2004)
N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease -: A Global Utilization of Strategies to Open occluded arteries (GUSTO)-IV substudy
SK James et al.
CIRCULATION (2003)
Current concepts: Renal dysfunction complicating the treatment of hypertension
BF Palmer
NEW ENGLAND JOURNAL OF MEDICINE (2002)
The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes
JA de Lemos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)